Open trial of bupropion SR in adolescent major depression.

Open trial of bupropion SR in adolescent major depression.
复制标题

安非他酮 SR 治疗青少年重度抑郁症的公开试验。

DOI:
--
复制
发表时间:
2003
影响因子:
1.5
通讯作者:
R. Baldessarini
R. Baldessarini
中科院分区:
--
文献类型:
--
作者:
C. Glod;A. Lynch;E. Flynn;C. Berkowitz;R. Baldessarini

文献摘要

参考文献

被引文献

相似文献

问题 很少有关于缓释安非他酮治疗青少年抑郁症的研究。 方法 通过广告和自我推荐招募了21名患有DSM-IV重度抑郁症的青少年; 11名开始研究药物治疗,并每周使用扩展的汉密尔顿抑郁评定量表(SIGH-SAD)以及临床总体印象改善(CGI-I)进行评定。 结果 在11例入组的受试者中,8例完成了为期8周的安非他酮SR试验。平均基线SIGH-SAD评分为31.3,显著降低74%,平均终点评分为8.2。11例受试者中有8例(72.3%)的CGI-I改善,评分者和患者之间的一致性非常接近。安非他酮SR的平均日剂量为362 mg +/- 52 mg,耐受性良好; 55%的受试者出现失眠和体重减轻;少数受试者出现口干、头痛、激越、头晕目眩、腹泻或皮疹等其他不良反应。 结论 在这项初步的小型开放性研究中,抑郁的青少年对安非他酮SR有明显的反应。
PROBLEM There are few studies of sustained-release bupropion in adolescents with major depression. METHODS Twenty-one adolescents with DSM-IV major depression were recruited through advertisement and self-referral; 11 began study medication and were rated weekly with an expanded Hamilton Depression Rating Scale (SIGH-SAD), as well as Clinical Global Impression-Improvement (CGI-I). RESULTS Of 11 subjects enrolled, 8 completed an 8-week trial of bupropion SR. Mean baseline SIGH-SAD scores of 31.3 decreased significantly by 74% to mean endpoint score of 8.2. Improvement on CGI-I that agreed closely between raters and patients was found in 8 of 11 subjects (72.3%). The mean daily dose of bupropion SR was 362 mg +/- 52 mg and was well tolerated; insomnia and weight loss were experienced by 55%; other adverse effects of dry mouth, headache, agitation, light-headedness, diarrhea, or rash were noted in a minority of subjects. CONCLUSIONS In this preliminary, small open study, depressed adolescents showed a marked response to bupropion SR.
DOI: 10.1097/00004583-200107000-00010
发表时间: 2001-07-01
影响因子: 13.3
作者:
Keller, MB;Ryan, ND;McCafferty, JP
通讯作者: McCafferty, JP
抗抑郁药相关的躁狂症:与自发躁狂症的对照比较。
DOI: 10.1176/ajp.151.11.1642
发表时间: 1994
期刊: The American journal of psychiatry
影响因子: --
作者:
Stoll,AL;Mayer,PV;Kolbrener,M;Goldstein,E;Suplit,B;Lucier,J;Cohen,BM;Tohen,M
通讯作者: Tohen,M
DOI: 10.1001/archpsyc.1997.01830230069010
发表时间: 1997-11
影响因子: --
作者:
G. Emslie;A. Rush;W. Weinberg;R. Kowatch;C. Hughes;T. Carmody;J. Rintelmann
通讯作者: G. Emslie;A. Rush;W. Weinberg;R. Kowatch;C. Hughes;T. Carmody;J. Rintelmann
德克萨斯州儿童药物算法项目:德克萨斯州共识会议小组关于儿童重度抑郁症药物治疗的报告。
DOI: 10.1097/00004583-199911000-00020
发表时间: 1999
期刊: Journal of the American Academy of Child and Adolescent Psychiatry.
影响因子: --
作者:
Hughes,CW;Emslie,GJ;Crismon,ML;Wagner,KD;Birmaher,B;Geller,B;Pliszka,SR;Ryan,ND;Strober,M;Trivedi,MH;Toprac,MG;Sedillo,A;Llana,ME;Lopez,M;Rush,AJ
通讯作者: Rush,AJ
DOI: 10.1097/00004583-199706000-00019
发表时间: 1997
期刊: Journal of the American Academy of Child and Adolescent Psychiatry.
影响因子: --
作者:
Swedo,SE;Allen,AJ;Glod,CA;Clark,CH;Teicher,MH;Richter,D;Hoffman,C;Hamburger,SD;Dow,S;Brown,C;Rosenthal,NE
通讯作者: Rosenthal,NE